Cargando…
The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies
The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...
Autores principales: | Rasetti-Escargueil, Christine, Avril, Arnaud, Miethe, Sebastian, Mazuet, Christelle, Derman, Yagmur, Selby, Katja, Thullier, Philippe, Pelat, Thibaut, Urbain, Remi, Fontayne, Alexandre, Korkeala, Hannu, Sesardic, Dorothea, Hust, Michael, Popoff, Michel R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666356/ https://www.ncbi.nlm.nih.gov/pubmed/28974033 http://dx.doi.org/10.3390/toxins9100309 |
Ejemplares similares
-
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody
por: Derman, Yağmur, et al.
Publicado: (2016) -
Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E
por: Miethe, Sebastian, et al.
Publicado: (2015) -
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B
por: Miethe, Sebastian, et al.
Publicado: (2016) -
Isolation of nanomolar scFvs of non-human primate origin, cross-neutralizing botulinum neurotoxins A(1) and A(2) by targeting their heavy chain
por: Avril, Arnaud, et al.
Publicado: (2015) -
Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B
por: Rasetti-Escargueil, Christine, et al.
Publicado: (2015)